5062-67-9

Basic information

• Product Name: (1-AMINOCYCLOHEXYL)METHYLAMINE DIHYDROCHLORIDE
• Synonyms: (1-AMINOCYCLOHEXYL)METHYLAMINE DIHYDROCHLORIDE;1-Aminocyclohexane-1-methanamine;1-Aminomethylcyclohexylamine;1-(Aminomethyl)cyclohexanamine;1-(aminomethyl)cyclohexan-1-amine dihydrochloride
• CAS NO: 5062-67-9
• Molecular Formula: C₇H₁₆N₂
• Molecular Weight: 128.22
• Mol File: 5062-67-9.mol

Chemical Properties

• Boiling Point: 182.5°C at 760 mmHg
• Flash Point: 73°C
• Appearance: /
• Density: 0.934g/cm³
• Vapor Pressure: 0.81mmHg at 25°C
• Refractive Index: 1.485
• PKA: 10.27±0.29(Predicted)
• CAS DataBase Reference: (1-AMINOCYCLOHEXYL)METHYLAMINE DIHYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: (1-AMINOCYCLOHEXYL)METHYLAMINE DIHYDROCHLORIDE(5062-67-9)
• EPA Substance Registry System: (1-AMINOCYCLOHEXYL)METHYLAMINE DIHYDROCHLORIDE(5062-67-9)

Safety Data

• Hazardous Substances Data: 5062-67-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
(1-AMINOCYCLOHEXYL)METHYLAMINE DIHYDROCHLORIDE is utilized as a key intermediate in the synthesis of various pharmacological agents and bioactive molecules. Its unique structure and reactivity make it a valuable component in creating new compounds with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, (1-AMINOCYCLOHEXYL)METHYLAMINE DIHYDROCHLORIDE is employed as a crucial building block for constructing complex organic molecules. Its properties allow for the development of a wide range of chemical compounds with diverse applications.
Used in the Development of Neurological Treatments:
(1-AMINOCYCLOHEXYL)METHYLAMINE DIHYDROCHLORIDE is explored for its potential role in the development of new drugs for the treatment of neurological disorders, such as Alzheimer's disease. Its unique characteristics make it a promising candidate for further research and development in this area.

InChI:InChI=1/C7H16N2/c8-6-7(9)4-2-1-3-5-7/h1-6,8-9H2

Upstream product

• 5496-10-6 1-amino-1-cyanocyclohexane 
• 123194-05-8 1-(aminomethyl)cyclohexan-1-amine dihydrochloride 
• 108-94-1 cyclohexanone 
• 110493-35-1 1-acetylamino-1-(acetylamino-methyl)-cyclohexane 

Downstream Products

• 61796-87-0 2-Ethyl-N-{1-[(2-ethyl-butyrylamino)-methyl]-cyclohexyl}-butyramide 
• 13157-24-9 1,3-diazaspiro[4.5]decane-2-thione 
• 1374743-00-6 trilaciclib 
• 1254048-03-7 5-{[(1-aminocyclohexyl)methyl]amino}-6-ethyl-3-{[3-(methylsulfonyl)phenyl]amino}pyrazine-2-carboxamide 
• 1254047-27-2 2-{[(1-aminocyclohexyl)methyl]amino}-4-{[3-(methylcarbamoyl)phenyl]amino}-6-oxo-1,6-dihydropyrimidine-5-carboxamide 
• 135524-89-9 (1R,6R,10S)-10-Phenyl-8,12-bis-(toluene-4-sulfonyl)-8,12-diaza-tricyclo[4.3.2.1^1,6]dodecan-10-ol 
• 135524-92-4 C₃₀H₃₄N₂O₅S₂ 
• 135524-77-5 C₂₁H₂₈N₂O₄S₂ 
• 61796-77-8 Undec-10-enoic acid [1-(undec-10-enoylamino-methyl)-cyclohexyl]-amide 

Relevant articles and documents

SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES

This invention is in the area of synthesizing pyrimidine-based compounds useful in the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

DIPEPTIDYL PEPTIDASE IV INHIBITOR

A compound represented by general formula (I):A-B-D whereinA represents a substituted or unsubstituted 1-pyrrolidinyl group, a substituted or unsubstituted 3-thiazolidinyl group, a substituted or unsubstituted 1-oxo-3-thiazolidinyl group, or the like;B r